Literature DB >> 11316066

A study of cytokine gene polymorphisms and protein secretion in renal transplantation.

N H Cartwright1, L J Keen, A G Demaine, N J Hurlock, R J McGonigle, P A Rowe, J F Shaw, R M Szydlo, E R Kaminski.   

Abstract

Although there is evidence that cytokine gene polymorphisms are associated with varying quantities of cytokine protein production, the exact role of these polymorphisms in allograft rejection remains unclear. In a previous study, we demonstrated a significant association between high IL-10 secretion in mixed lymphocyte culture (MLC), together with HLA mismatching for at least 4-6 antigens, with the occurrence of acute rejection following renal transplantation. We, therefore, wished to ascertain whether cytokine gene polymorphisms are associated with varying levels of protein secretion and/or allograft rejection in the same group of patients. Cytokine protein secretion in MLC for IL-4, IL-6, IL-10 and IFN-gamma was measured by ELISA in 49 patient-donor pairs. Protein secretion for the above cytokines was also measured in phytohaemagglutinin (PHA) stimulated cultures in 30 normal controls. In both patient and control groups, single nucleotide polymorphism analysis for IL-4 G(-590)T, IL-6 G(-174)C, IL-10 G(-1082)A, IL-10 C(-819)T, IL-10 C(-592)A, TNF-alpha G(-308)A and microsatellite analysis for IFNG (CA repeat) was performed. No correlation was found between cytokine gene polymorphisms and cytokine protein secretion in either mitogen stimulated cultures (control group) or MLC (patient group). In addition, no correlation was demonstrated between cytokine gene polymorphisms and renal allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316066     DOI: 10.1016/s0966-3274(01)00026-0

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  7 in total

1.  Intragraft expression of the IL-10 gene is up-regulated in renal protocol biopsies with early interstitial fibrosis, tubular atrophy, and subclinical rejection.

Authors:  Miguel Hueso; Estanis Navarro; Francesc Moreso; Francisco O'Valle; Mercè Pérez-Riba; Raimundo García Del Moral; Josep M Grinyó; Daniel Serón
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

2.  A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients.

Authors:  Mohammad Hossein Karimi; Saeed Daneshmandi; Ali Akbar Pourfathollah; Bita Geramizadeh; Ramin Yaghobi; Ghanbar Ali Rais-Jalali; Jamshid Roozbeh; Shahram Bolandparvaz
Journal:  Mol Biol Rep       Date:  2011-05-12       Impact factor: 2.316

3.  Interleukin-10-1082G/A polymorphism and acute liver graft rejection: a meta-analysis.

Authors:  Fei Liu; Bo Li; Wen-Tao Wang; Yong-Gang Wei; Lv-Nan Yan; Tian-Fu Wen; Ming-Qing Xu; Jia-Yin Yang
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

4.  The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection.

Authors:  G K Chin; C L Adams; B S Carey; S Shaw; W-Y Tse; E R Kaminski
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

5.  Interleukin-10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea.

Authors:  Ho Jun Chin; Ki Young Na; Soo Jin Kim; Kook-Hwan Oh; Yon Su Kim; Chun Soo Lim; Suhnggwon Kim; Dong-Wan Chae
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

6.  Influence of recipient and donor IL-10, TNFA and INFG genotypes on the incidence of acute renal allograft rejection.

Authors:  Negar Azarpira; Mahdokht H Aghdai; Ghanbar A Raisjalali; Masumeh Darai; Moham J Tarahi
Journal:  Mol Biol Rep       Date:  2008-09-16       Impact factor: 2.316

7.  Influence of recipient and donor IL-1alpha, IL-4, and TNFalpha genotypes on the incidence of acute renal allograft rejection.

Authors:  H Lee; B Clark; H C Gooi; J Stoves; C G Newstead
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.